DeltaNp63 Is a Protective Marker of Progression in HGT1 Bladder Cancer

被引：0
|
作者：
Castillo-Martin, M.
Sopena, J. M. Gaya
Gladoun, N.
Karni-Schmidt, O.
Gonzalez, C.
Algaba, F.
Redorta, J. Palou
Cordon-Cardo, C.
机构：
[1] Mt Sinai Med Ctr, Mt Sinai Sch Med, New York, NY 10029 USA
[2] Fundacio Puigvert, Barcelona, Spain
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
823
引用
收藏
页码：199A / 200A
页数：2
相关论文
共 50 条
  • [1] DeltaNp63 Is a Protective Marker of Progression in HGT1 Bladder Cancer
    Castillo-Martin, M.
    Gaya Sopena, J. M.
    Gladoun, N.
    Karni-Schmidt, O.
    Gonzalez, C.
    Algaba, F.
    Palou Redorta, J.
    Cordon-Cardo, C.
    LABORATORY INVESTIGATION, 2013, 93 : 199A - 200A
  • [2] The role of deltaNp63 in the progression and chemoresistance of pediatric osteosarcoma
    Cam, Maren
    Charan, Manish
    Setty, Bhuvana
    Cam, Hakan
    CLINICAL CANCER RESEARCH, 2018, 24 (02) : 48 - 48
  • [3] DELTAN P63 (ΔNP63) EXPRESSION AS A PROGNOSTIC FACTOR OF PROGRESSION IN CLINICAL HGT1 BLADDER CANCER.
    Gaya, Josep Maria
    Castillo-Martin, Mireia
    Manuel Lopez-Martinez, Juan
    Karni-Schmidt, Orit
    Gladoun, Nataliya
    Algaba, Ferran
    Palou, Joan
    Villavicencio, Humberto
    Benson, Mitchell C.
    Cordon-Cardo, Carlos
    JOURNAL OF UROLOGY, 2012, 187 (04): : E158 - E158
  • [4] DeltaNp63 is critical for progression of high grade non-muscle invasive bladder cancer through deregulation of specific genetic pathways
    Castillo-Martin, M.
    Gladoun, N.
    Collazo-Lorduy, A.
    Cordon-Cardo, C.
    VIRCHOWS ARCHIV, 2016, 469 : S15 - S15
  • [5] DeltaNp63 Isoforms of p63 in Aberrant Diffuse p63 Positive Prostate Cancer
    Uchida, K.
    Ross, H. M.
    Epstein, J. I.
    Lotan, T.
    Illei, P. B.
    MODERN PATHOLOGY, 2012, 25 : 247A - 247A
  • [6] DeltaNp63 Isoforms of p63 in Aberrant Diffuse p63 Positive Prostate Cancer
    Uchida, K.
    Ross, H. M.
    Epstein, J. I.
    Lotan, T.
    Illei, P. B.
    LABORATORY INVESTIGATION, 2012, 92 : 247A - 247A
  • [7] MASPIN AND DELTANP63 EXPRESSION IN OPERABLE NON-SMALL CELL LUNG CANCER (NSCLC)
    Lee, Min Ki
    RESPIROLOGY, 2010, 15 : 70 - 70
  • [8] Differential expression of p63 isoforms: TAp63 and DeltaNp63 counterbalance in colorectal cancer among 63 Tunisian patients
    Bouraoui, S.
    Boughriba, R.
    Houimli, A.
    Dhaou, A.
    Weslati, M.
    Ounissi, D.
    Hazgui, M.
    Chaar, I.
    Amara, S.
    Dhraief, M.
    Mezabi, S. Regaya
    VIRCHOWS ARCHIV, 2015, 467 : S162 - S162
  • [9] Genomic predictors of recurrence (R) or progression (P) in high grade T1 (HGT1) non-muscle invasive (NMI) bladder cancer
    Bellmunt, Joaquim
    Kim, Jaegil
    Mullane, Stephanie A.
    Reardon, Brendan
    Orsola, Anna
    VanAllen, Eliezer
    Getz, Gad
    Kwiatkowski, David J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] PROPOSAL FOR INCLUDING SUBSTAGING OF HGT1 BLADDER CANCER IN THE TNM CLASSIFICATION: A SYSTEMATIC REVIEW AND META-ANALYSIS BASED ON 2678 PATIENTS
    Orsola, Anna
    Martin-Doyle, William
    Leow, Jeffrey J.
    Bellmunt, Joaquim
    JOURNAL OF UROLOGY, 2014, 191 (04): : E696 - E697
12345